|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Current derivative financial instruments | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Deferred income tax assets, net | ||||||||||||||||||||
| Intangibles, net | ||||||||||||||||||||
| Derivative financial instruments | ||||||||||||||||||||
| Other noncurrent assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt (less current portion) | ||||||||||||||||||||
| Noncurrent income tax liabilities | ||||||||||||||||||||
| Deferred income tax liabilities, net | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Mezzanine equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value Authorized - 1,000,000 shares Issued and outstanding - 150,000 shares outstanding at September 30, 2025 and December 31, 2024 | ||||||||||||||||||||
| Noncontrolling redeemable equity | ||||||||||||||||||||
| Shareholders' equity (deficit): | ||||||||||||||||||||
| Common stock, $0.01 par value Authorized - 100,000,000 shares Issued and outstanding - 37,298,422 and 28,886,053 shares at September 30, 2025 and December 31, 2024 | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Retained earnings (deficit) | ||||||||||||||||||||
| Total shareholders' equity (deficit) | ||||||||||||||||||||
| Total liabilities, mezzanine equity and shareholders' equity (deficit) | ||||||||||||||||||||
Loading...
